K25: Next generation molecular diagnostics for therapy decisions and discovery for all patients with newly diagnosed glioblastoma without MGMT promoter methylation [NCT Neuro Master Match (N2M2) Diagnostics]

HIPO Investigator:

Prof. Dr. Wolfgang Wick

Prof. Dr. Andreas von Deimling

Prof. Dr. Stefan Pfister

Prof. Dr. Christel Herold-Mende

Prof. Dr. Benedikt Brors

Prof. Dr. Jürgen Debus


Supported by: HIPO

Entity: Glioblastoma

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.